Sjogren's Mini-Pill Oral and Gut Microbiome Study
NCT07732582 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2026-07-29
Summary
The goal of this observational study is to characterize and compare region-specific gastrointestinal, stool, oral, and periodontal microbiomes in adults with Sjögren's disease and healthy controls using ingestible mini-pill sampling technology. The study will include adults with Sjögren's disease and healthy control participants enrolled in a parent gastrointestinal microbiome study
Conditions
- Sjogren's Syndrome
Interventions
- DEVICE
-
Mini-Pill
Collection of region-specific gastrointestinal microbiome samples using ingestible mini-pill technology for microbiome characterization and comparison between adults with Sjögren's disease and healthy controls.
Sponsors & Collaborators
-
Tufts University
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-08-31
- Primary Completion
- 2027-08-31
- Completion
- 2028-08-31
Countries
- United States
Study Locations
More Related Trials
-
COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States
NCT05020145 ·Status: COMPLETED
-
Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant
NCT06768697 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Induction of Gut Permeability by an Oral Vaccine
NCT04083950 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Rapamycin and Infection-related Illness
NCT07054320 ·Status: ACTIVE_NOT_RECRUITING
-
An Investigational Study to Evaluate the Effect of Rifampin on the Singe Dose of Experimental Medication BMS-986224 in Healthy Participants
NCT03563950 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Characterize the Elimination of Guselkumab Glycoform Variants in Healthy Participants
NCT02570373 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-Finding Study of Lyophilized Shigella Sonnei 53G Challenge Strain
NCT02816346 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19 Omicron) mRNA Vaccine (Phase 1)
NCT05433194 ·Status: UNKNOWN ·Phase: PHASE1
-
Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine Regimens in Adult Participants Hospitalized With Respiratory Syncytial Virus
NCT02935673 ·Status: TERMINATED ·Phase: PHASE2
-
Phase 1, Single Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MEDI5884
NCT03001297 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine.
NCT05043285 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years
NCT05522829 ·Status: UNKNOWN ·Phase: PHASE2
-
First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects
NCT04893512 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a
NCT02388009 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults
NCT00679172 ·Status: COMPLETED ·Phase: PHASE2
-
This Trial is a Clinical Performance Validation Study That Will Evaluate the Clinical Agreement of the Sky Medical™ Rapid Antigen Test Comparing the Antigen Rapid Test to RT-PCR
NCT05491993 ·Status: UNKNOWN ·Phase: NA
-
Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR)
NCT02445963 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of FMT Capsules in Healthy Volunteers
NCT05352269 ·Status: UNKNOWN ·Phase: PHASE1
-
A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine
NCT05652543 ·Status: COMPLETED ·Phase: PHASE2
-
Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine
NCT00210288 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers
NCT05188469 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tocilizumab in COVID-19 Lahore General Hospital
NCT04560205 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19
NCT05817045 ·Status: COMPLETED ·Phase: NA
-
Study to Safety, Tolerability and Immunogenicity of EG-COVII in Healthy Adult
NCT06099613 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease
NCT00350298 ·Status: COMPLETED ·Phase: PHASE2